|
C14ORF135 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.45719991628823E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.238400E-04 |
| Normal-vs-Stage2 |
1.363880E-02 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
7.82820475109247E-11 |
| Stage1-vs-Stage2 |
7.677200E-01 |
| Stage1-vs-Stage3 |
1.66153999999752E-05 |
| Stage1-vs-Stage4 |
2.117100E-03 |
| Stage2-vs-Stage3 |
3.314100E-02 |
| Stage2-vs-Stage4 |
8.616300E-02 |
| Stage3-vs-Stage4 |
6.403600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.22919954401868E-10 |
| Normal-vs-AfricanAmerican |
5.22880000408676E-08 |
| Normal-vs-Asian |
1.896200E-02 |
| Caucasian-vs-AfricanAmerican |
5.023200E-01 |
| Caucasian-vs-Asian |
7.201600E-01 |
| AfricanAmerican-vs-Asian |
5.978000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.64689999812862E-08 |
| Normal-vs-Female |
4.49349446540737E-11 |
| Male-vs-Female |
4.235000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.382600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.7126399999956E-05 |
| Normal-vs-Age(61-80Yrs) |
9.78339964596842E-10 |
| Normal-vs-Age(81-100Yrs) |
1.07430000451103E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.713840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.708000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.662600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.593810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.362150E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.291180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.260400E-01 |
| Normal-vs-Grade 2 |
1.92470000004441E-06 |
| Normal-vs-Grade 3 |
5.31279999993473E-08 |
| Normal-vs-Grade 4 |
3.28070903776734E-13 |
| Grade 1-vs-Grade 2 |
3.349700E-02 |
| Grade 1-vs-Grade 3 |
4.337300E-03 |
| Grade 1-vs-Grade 4 |
1.64430999999299E-05 |
| Grade 2-vs-Grade 3 |
2.179800E-01 |
| Grade 2-vs-Grade 4 |
1.630270E-04 |
| Grade 3-vs-Grade 4 |
1.495570E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.37369999948001E-07 |
| Normal-vs-ccB subtype |
6.969400E-04 |
| ccA subtype-vs-ccB subtype |
8.900600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.19109999999301E-05 |
| Normal-vs-N1 |
9.78109815363837E-11 |
| N0-vs-N1 |
3.832700E-04 |
|
|
